A novel role for granzymes in anti-tumor immunity

Sabine Hoves1, Vivien R Sutton, Joseph A Trapani

  • 1Ludwig Maximilian University of Munich; Division of Clinical Pharmacology and Medical Clinic; Munich, Germany.

Oncoimmunology
|June 22, 2012
PubMed

Insights

Granzymes, known for cell killing, also regulate immune responses. They trigger "eat-me" signals on tumor cells, enhancing their removal by dendritic cells for effective antigen presentation.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Granzymes are serine proteases traditionally recognized for their cytotoxic functions.
  • Emerging evidence suggests broader roles for granzymes beyond direct cell killing, particularly in immune regulation.

Purpose of the Study:

  • To investigate the non-cytotoxic functions of granzymes in the context of anti-tumor immunity.
  • To elucidate the mechanism by which granzymes influence antigen presentation by dendritic cells.

Main Methods:

  • Utilized in vitro co-culture systems involving dendritic cells and tumor cells.
  • Employing biochemical assays to detect granzyme activity and cellular signals.
  • Flow cytometry and confocal microscopy to analyze phagocytosis and antigen presentation.

Main Results:

  • Demonstrated that granzymes induce specific "eat-me" signals on the surface of dying tumor cells.
  • Showed that these granzyme-mediated signals enhance the phagocytic capacity of dendritic cells.
  • Confirmed efficient uptake and cross-presentation of tumor-associated antigens by dendritic cells.

Conclusions:

  • Granzymes play a crucial regulatory role in the immune response to tumors.
  • By promoting phagocytosis of tumor debris, granzymes facilitate cross-presentation of tumor antigens.
  • This mechanism highlights a novel pathway for enhancing anti-tumor immunity through granzyme modulation.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...